Cargando…

Decision curve analysis revisited: overall net benefit, relationships to ROC curve analysis, and application to case-control studies

BACKGROUND: Decision curve analysis has been introduced as a method to evaluate prediction models in terms of their clinical consequences if used for a binary classification of subjects into a group who should and into a group who should not be treated. The key concept for this type of evaluation is...

Descripción completa

Detalles Bibliográficos
Autores principales: Rousson, Valentin, Zumbrunn, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148204/
https://www.ncbi.nlm.nih.gov/pubmed/21696604
http://dx.doi.org/10.1186/1472-6947-11-45
_version_ 1782209322900520960
author Rousson, Valentin
Zumbrunn, Thomas
author_facet Rousson, Valentin
Zumbrunn, Thomas
author_sort Rousson, Valentin
collection PubMed
description BACKGROUND: Decision curve analysis has been introduced as a method to evaluate prediction models in terms of their clinical consequences if used for a binary classification of subjects into a group who should and into a group who should not be treated. The key concept for this type of evaluation is the "net benefit", a concept borrowed from utility theory. METHODS: We recall the foundations of decision curve analysis and discuss some new aspects. First, we stress the formal distinction between the net benefit for the treated and for the untreated and define the concept of the "overall net benefit". Next, we revisit the important distinction between the concept of accuracy, as typically assessed using the Youden index and a receiver operating characteristic (ROC) analysis, and the concept of utility of a prediction model, as assessed using decision curve analysis. Finally, we provide an explicit implementation of decision curve analysis to be applied in the context of case-control studies. RESULTS: We show that the overall net benefit, which combines the net benefit for the treated and the untreated, is a natural alternative to the benefit achieved by a model, being invariant with respect to the coding of the outcome, and conveying a more comprehensive picture of the situation. Further, within the framework of decision curve analysis, we illustrate the important difference between the accuracy and the utility of a model, demonstrating how poor an accurate model may be in terms of its net benefit. Eventually, we expose that the application of decision curve analysis to case-control studies, where an accurate estimate of the true prevalence of a disease cannot be obtained from the data, is achieved with a few modifications to the original calculation procedure. CONCLUSIONS: We present several interrelated extensions to decision curve analysis that will both facilitate its interpretation and broaden its potential area of application.
format Online
Article
Text
id pubmed-3148204
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31482042011-08-02 Decision curve analysis revisited: overall net benefit, relationships to ROC curve analysis, and application to case-control studies Rousson, Valentin Zumbrunn, Thomas BMC Med Inform Decis Mak Correspondence BACKGROUND: Decision curve analysis has been introduced as a method to evaluate prediction models in terms of their clinical consequences if used for a binary classification of subjects into a group who should and into a group who should not be treated. The key concept for this type of evaluation is the "net benefit", a concept borrowed from utility theory. METHODS: We recall the foundations of decision curve analysis and discuss some new aspects. First, we stress the formal distinction between the net benefit for the treated and for the untreated and define the concept of the "overall net benefit". Next, we revisit the important distinction between the concept of accuracy, as typically assessed using the Youden index and a receiver operating characteristic (ROC) analysis, and the concept of utility of a prediction model, as assessed using decision curve analysis. Finally, we provide an explicit implementation of decision curve analysis to be applied in the context of case-control studies. RESULTS: We show that the overall net benefit, which combines the net benefit for the treated and the untreated, is a natural alternative to the benefit achieved by a model, being invariant with respect to the coding of the outcome, and conveying a more comprehensive picture of the situation. Further, within the framework of decision curve analysis, we illustrate the important difference between the accuracy and the utility of a model, demonstrating how poor an accurate model may be in terms of its net benefit. Eventually, we expose that the application of decision curve analysis to case-control studies, where an accurate estimate of the true prevalence of a disease cannot be obtained from the data, is achieved with a few modifications to the original calculation procedure. CONCLUSIONS: We present several interrelated extensions to decision curve analysis that will both facilitate its interpretation and broaden its potential area of application. BioMed Central 2011-06-22 /pmc/articles/PMC3148204/ /pubmed/21696604 http://dx.doi.org/10.1186/1472-6947-11-45 Text en Copyright ©2011 Rousson and Zumbrunn; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Correspondence
Rousson, Valentin
Zumbrunn, Thomas
Decision curve analysis revisited: overall net benefit, relationships to ROC curve analysis, and application to case-control studies
title Decision curve analysis revisited: overall net benefit, relationships to ROC curve analysis, and application to case-control studies
title_full Decision curve analysis revisited: overall net benefit, relationships to ROC curve analysis, and application to case-control studies
title_fullStr Decision curve analysis revisited: overall net benefit, relationships to ROC curve analysis, and application to case-control studies
title_full_unstemmed Decision curve analysis revisited: overall net benefit, relationships to ROC curve analysis, and application to case-control studies
title_short Decision curve analysis revisited: overall net benefit, relationships to ROC curve analysis, and application to case-control studies
title_sort decision curve analysis revisited: overall net benefit, relationships to roc curve analysis, and application to case-control studies
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148204/
https://www.ncbi.nlm.nih.gov/pubmed/21696604
http://dx.doi.org/10.1186/1472-6947-11-45
work_keys_str_mv AT roussonvalentin decisioncurveanalysisrevisitedoverallnetbenefitrelationshipstoroccurveanalysisandapplicationtocasecontrolstudies
AT zumbrunnthomas decisioncurveanalysisrevisitedoverallnetbenefitrelationshipstoroccurveanalysisandapplicationtocasecontrolstudies